Profil
Todd A. Verdoorn was the founder of Algos Therapeutics, Inc. founded in 2003, where he held the title of Chief Operating & Scientific Officer from 2003 to 2007.
He was also the Chief Scientific Officer at DiaMedica Therapeutics, Inc. from 2016 to 2019.
Dr. Verdoorn's former positions include being the Chief Scientific Officer at Orasi Medical, Inc. from 2008 to 2011, Vice President-Neurobiology at NeuroTherapeutics Pharma, Inc. from 2011 to 2013, and Chief Scientist at Intuitive Quantitation LLC from 2013 to 2016.
He also held positions at Bristol-Myers Squibb Pharmaceutical Research Institute, Vanderbilt University, Max-Planck-Institute for Molecular Genetics, and Smart Bioscience SAS. Dr. Verdoorn's education includes an undergraduate degree from Central College and a doctorate from The University of North Carolina at Asheville.
Anciens postes connus de Todd A. Verdoorn
| Sociétés | Poste | Fin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 15/11/2019 |
Intuitive Quantitation LLC | Corporate Officer/Principal | 01/12/2016 |
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Corporate Officer/Principal | 01/05/2013 |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Develops neurological diagnostics products | Directeur Technique/Scientifique/R&D | 01/08/2011 |
Smart Bioscience SAS | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Formation de Todd A. Verdoorn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Central College
Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Develops neurological diagnostics products | Health Services |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
Algos Therapeutics, Inc.
Algos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Specializes in preclinical in vivo pain research and program consulting | Health Technology |
The University of North Carolina at Asheville
The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intuitive Quantitation LLC | |
Smart Bioscience SAS |
















